Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program
-
Dyadic Expands IP Protection and Business Development Activities in Japan
-
Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption
-
Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor Conference
-
Dyadic to Report Q1 2026 Financial Results and Host Conference Call on Wednesday May 13, 2026
-
DYADIC ANNOUNCES 2025 FINANCIAL RESULTS AND HIGHLIGHTS RECENT COMPANY PROGRESS
-
Dyadic to Report Year 2025 Financial Results
-
Dyadic Applied BioSolutions Establishes Commercial Partnership to Accelerate Adoption of Dyadic’s Recombinant Growth Factors and Media Proteins
-
Dyadic Announces Third Quarter 2025 Financial Results and Highlights Strategic Progress
-
Dyadic to Report Third Quarter 2025 Financial Results on Wednesday, November 12, 2025